Vanderbilt University Medical Center
Infectious Disease fellowship · Nashville, TN · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is Vanderbilt University Medical Center's research in infectious disease, which the program shares with other departments and affiliated hospitals.
About Vanderbilt University Medical Centerinstitution-wide infectious disease research
Infectious Disease publications from Vanderbilt University Medical Center and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
174
works per year
12th of 71 infectious disease fellowship programs
-43.7%
2-year growth
56th of 71 infectious disease fellowship programs
36.3%
in top 10% of field (works before 2025)
3rd of 67 infectious disease fellowship programs
60.1%
cited above world average
6th of 67 infectious disease fellowship programs
Works per year · * 2026 so far
Infectious Diseases · 810
Infectious Disease research topics at Vanderbilt University Medical Center
Papers in the window; each links to the list on OpenAlex.
- SARS-CoV-2 and COVID-19 Research 171
- HIV/AIDS Research and Interventions 134
- COVID-19 Clinical Research Studies 132
- Tuberculosis Research and Epidemiology 100
- Clostridium difficile and Clostridium perfringens research 41
- Antimicrobial Resistance in Staphylococcus 31
- HIV/AIDS drug development and treatment 30
- Antifungal resistance and susceptibility 24
Most cited at Vanderbilt University Medical Center since 2024
All infectious disease papers there on OpenAlex
- Multidrug-resistant tuberculosisKeertan U.J. Dheda et al. · Nature Reviews Disease Primers · 2024 · PubMed · cited 265
- Interim Estimates of 2024–2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years — VISION and IVY Networks, September 2024–January 2025Ruth Link‐Gelles et al. · MMWR Morbidity and Mortality Weekly Report · 2025 · PubMed · cited 90
- Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccinesChieh-Yu Liang et al. · Nature · 2024 · PubMed · cited 90
- SARS-CoV-2 shedding and evolution in patients who were immunocompromised during the omicron period: a multicentre, prospective analysisZoe Raglow et al. · The Lancet Microbe · 2024 · PubMed · cited 90
- Infectious Diseases Society of America Guidelines on the Diagnosis of Coronavirus Disease 2019: Serologic TestingMary K. Hayden et al. · Clinical Infectious Diseases · 2024 · PubMed · cited 89
- The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: A modeling studyKeri N. Althoff et al. · PLoS Medicine · 2024 · PubMed · cited 85
- Restriction of arginine induces antibiotic tolerance in Staphylococcus aureusJeffrey A. Freiberg et al. · Nature Communications · 2024 · PubMed · cited 75
- Vaccine Effectiveness Against Long COVID in ChildrenHanieh Razzaghi et al. · PEDIATRICS · 2024 · PubMed · cited 73
- Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years — VISION and IVY Networks, September 2023–January 2024Jennifer DeCuir et al. · MMWR Morbidity and Mortality Weekly Report · 2024 · PubMed · cited 70
- Favorable Antiviral Effect of Metformin on SARS-CoV-2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of COVID-19Carolyn T. Bramante et al. · Clinical Infectious Diseases · 2024 · PubMed · cited 62